Doxorubicin Depletes Glutathione in HeLa Cells
Author Information
Author(s): M. Al-Kabban, I.D. Watson, M.J. Stewart, J. Reglinski, W.E. Smith, C.J. Suckling
Primary Institution: Department of Pathological Biochemistry, Glasgow Royal Infirmary; Department of Pure and Applied Chemistry, University of Strathclyde
Hypothesis
Does doxorubicin induce depletion of glutathione in HeLa cells?
Conclusion
Doxorubicin significantly depletes glutathione levels in HeLa cells, which can be partially reversed by N-acetylcysteine and cysteine treatment.
Supporting Evidence
- Doxorubicin treatment led to an 88% depletion of glutathione after 12 hours.
- N-acetylcysteine and cysteine pretreatment provided protective effects against glutathione depletion.
- Both HPLC and NMR methods confirmed the depletion of glutathione in HeLa cells.
Takeaway
Doxorubicin, a cancer drug, can lower a protective substance in cells called glutathione, but giving certain other substances can help keep it safe.
Methodology
The study used 1H spin echo NMR and HPLC to measure glutathione and lactate levels in HeLa cells treated with doxorubicin.
Limitations
The study may not fully account for all cellular responses to doxorubicin and the protective effects of thiols.
Participant Demographics
HeLa cells, a human cervical cancer cell line.
Statistical Information
P-Value
p<0.05
Statistical Significance
p<0.05
Want to read the original?
Access the complete publication on the publisher's website